References
- Said S I, Mutt V., Erdos E G. The lung in relation to vasoactive polypeptides. In: Ciba Symposium 78: Metabolic Activities of the Lung. Elsevier Science Publishing Co., Amsterdam 1980; 217–237
- Said S I. Vasoactive peptides and the pulmonary circulation. Ann NY Acad Sci, in press
- Gastrointestinal hormones. Comprehensive Endocrinology, G B Jerzy Glass, L Martini. Raven Press, New York 1980
- Ryan U S, Ryan J W, Whitaker C., Chiu A. Localization of angiotension converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 1976; 8: 125–145
- Wharton J J, Polak S R, Bloom S R, et al. Bombesin-like immunoreactivity in the lung. Nature (Lond) 1978; 273: 769–770
- Lewis R A, Austen K F. Nonrespiratory functions of pulmonary cells: The mast cell. Fed Proc 1977; 36: 2676–6383
- Said S I, Mutt V. Long acting vasodilator peptide from lung tissue. Nature (Lond) 1969; 224: 699–700
- Said S I, Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science 1970; 169: 1217–1218
- Said S I, Giachetti A., Nicosia S. VIP: Possible functions as a neural peptide. Neural Peptides and Neuronal Communications, E Costa, M Trabucchi. Raven Press, New York 1980; 75–82
- Uddman R., Alumets J., Densert O., et al. Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolarygol 1978; 367: 1–6
- Dey D A, Shannon W A, Said S I. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cata and human subjects. Cell Tissue Res 1981; 220: 231–238
- Said S I, Geumei A., Hara N. Bronchodilator effect of VIP in vivo: Protection against bronchoconstriction induced by histamine or prostaglandin F2α. Vasoactive Intestinal Peptide, S I Said. Raven Press, New York 1982; 185–192
- Wasserman M A, Griffin R I., Malo P E. Comparative in vitro tracheal-relaxant effects of porcine and hen VIP. Vasoactive Intestinal Peptide, S I Said. Raven Press, New York 1982; 177–184
- Hamasaki Y., Said S I. Vasodilator effects of vasoactive intestinal peptide (VIP) and prostacyclin (PGI2) on isolated cat pulmonary artery. Am Rev Respir Dis 1981; 122: 239
- Mojarad M., Said S I. Vasoactive intestinal peptide (VIP) dilates pulmonary vessels in anesthetized cats. Am Rev Respir Dis 1981; 122: 239
- Richardson J B. Nerve supply to the lungs. Am Rev. Respir Dis 1979; 119: 785–802
- Richardson J., Beland J. Nonadrenergic inhibitory nervous sytem in human airways. J Appl Physiol 1976; 41(5)764–771
- Burnstock G. Purinergic transmission. Handbook of Psychopharmacology Synaptic Modulators, L L Iversen, S D Iversen, S H Snyder. Plenum, New York 1975; vol. 5.: 131–195
- Matsuzaki Y., Hamasaki Y., Said S I. Vasoactive intestinal peptide: A possible transmitter of non-adrenergic relaxation of guinea pig airways. Science 1980; 210: 1252–1253
- Hamasaki Y., Said S I. Evidence for a non-adrenergic, noncholinergic inhibitory nervous system in cat pulmonary artery. Clin Res 1981; 29: 550A
- Said S I. Vasoactive Intestinal Peptide. Raven Press, New York 1982
- Hutto R., Granger D N, Taylor A E. Effects of vasoactive intestinal polypeptide on potential and short-circuit current in isolated dog tracheal epithelial sheets. Physiologist 1979; 22: 59
- Coles S J, Said S I, Reid L M. Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airway in vitro. Am Rev Respir Dis 1981; 124: 531–536